Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Jameson

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Archives of Disease in Childhood|December 21, 2010
Question 3 Ketamine or midazolam: does it matter which?Elisabeth Jameson
Pediatric Cardiology|December 7, 2007
Cardiac arrest secondary to long QT(C )in a child with propionic acidemiaElisabeth Jameson, John Walter
The Cochrane Database of Systematic Reviews|July 17, 2020
Dietary interventions for phenylketonuriaElisabeth Jameson, Tracey Remmington
The Cochrane Database of Systematic Reviews|June 19, 2019
Enzyme replacement therapy with laronidase (Aldurazyme<sup>®</sup>) for treating mucopolysaccharidosis type IElisabeth Jameson, Simon Jones, Tracey Remmington
The Cochrane Database of Systematic Reviews|April 2, 2016
Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type IElisabeth Jameson, Simon Jones, Tracey Remmington
The Cochrane Database of Systematic Reviews|October 3, 2013
Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type IElisabeth Jameson, Simon Jones, James E Wraith
The Cochrane Database of Systematic Reviews|November 22, 2013
Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type IElisabeth Jameson, Simon Jones, James E Wraith
The Journal of Pediatrics|October 30, 2016
Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type ISarah Laraway, Jean Mercer, Elisabeth Jameson, et al.
The British Journal of Ophthalmology|July 26, 2015
Optic neuropathy in methylmalonic acidemia and propionic acidemiaLidia Martinez Alvarez, Elisabeth Jameson, Neil R A Parry, et al.
American Journal of Medical Genetics. Part A|October 25, 2016
Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open-label, phase 2 studyPaul R Harmatz, Eugen Mengel, Tarekegn Geberhiwot, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Archives of Disease in Childhood|December 21, 2010
Question 3 Ketamine or midazolam: does it matter which?Elisabeth Jameson
Pediatric Cardiology|December 7, 2007
Cardiac arrest secondary to long QT(C )in a child with propionic acidemiaElisabeth Jameson, John Walter
The Cochrane Database of Systematic Reviews|July 17, 2020
Dietary interventions for phenylketonuriaElisabeth Jameson, Tracey Remmington
The Cochrane Database of Systematic Reviews|June 19, 2019
Enzyme replacement therapy with laronidase (Aldurazyme<sup>®</sup>) for treating mucopolysaccharidosis type IElisabeth Jameson, Simon Jones, Tracey Remmington
The Cochrane Database of Systematic Reviews|April 2, 2016
Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type IElisabeth Jameson, Simon Jones, Tracey Remmington
The Cochrane Database of Systematic Reviews|October 3, 2013
Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type IElisabeth Jameson, Simon Jones, James E Wraith
The Cochrane Database of Systematic Reviews|November 22, 2013
Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type IElisabeth Jameson, Simon Jones, James E Wraith
The Journal of Pediatrics|October 30, 2016
Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type ISarah Laraway, Jean Mercer, Elisabeth Jameson, et al.
The British Journal of Ophthalmology|July 26, 2015
Optic neuropathy in methylmalonic acidemia and propionic acidemiaLidia Martinez Alvarez, Elisabeth Jameson, Neil R A Parry, et al.
American Journal of Medical Genetics. Part A|October 25, 2016
Impact of elosulfase alfa in patients with morquio A syndrome who have limited ambulation: An open-label, phase 2 studyPaul R Harmatz, Eugen Mengel, Tarekegn Geberhiwot, et al.
Pageof 2